A practical reference on thymosin beta-4: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Thymosin beta-4 is a 43-residue actin-binding protein found in most mammalian cell types, where it participates in cytoskeletal regulation and cell migration. TB-500 represents only a short fragment of that protein and does not include the remaining residues. Whether the isolated fragment reproduces the full range of activities reported for the intact protein remains an open question. Researchers commonly treat the two as related but distinct entities when comparing results.
Published work involving this sequence spans actin-binding assays, cell-migration studies, wound-healing models, and cardiovascular or musculoskeletal experiments. Much of the biological rationale derives from in vitro systems and animal models, and the number of controlled human studies is small. Reported outcomes vary across preparations, doses, and routes, which complicates comparison between studies. Reviews generally describe the evidence base as preliminary rather than settled. Mechanistic explanations are often proposed by analogy to the parent protein rather than demonstrated directly.
TB-500 is a synthetic seven-amino-acid peptide with the sequence LKKTETQ, corresponding to residues 17 through 23 of the protein thymosin beta-4. The N-terminus is typically acetylated in the described form, giving a monoisotopic mass near 888.5 Da and an average mass of about 889 Da. The designation TB-500 is a catalogue label rather than a formal chemical name, and the same sequence appears in the literature under several alternative abbreviations. It is handled as a research reagent rather than a pharmaceutical product.
| Property | Value | Notes |
|---|---|---|
| Typical form | Lyophilised powder | Reconstituted before use |
| Storage temperature, dry | -20 °C or below | Desiccated, protected from light |
| Purity determination | Reversed-phase HPLC | Reported as percentage of total peak area |
| Identity confirmation | Mass spectrometry | ESI or MALDI-TOF versus calculated mass |
| Common synonyms | Tβ4 fragment; thymosin beta-4 fragment | Naming varies between suppliers |
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
== Non-classical examples of PLP == PLP is also found on glycogen phosphorylase in the liver, where it is used to break down glycogen in glycogenolysis when glucagon or epinephrine signals it to do so. However, this enzyme does not exploit the reactive aldehyde group, but instead utilizes the phosphate group on PLP to perform its reaction. Although the vast majority of PLP-dependent enzymes form an internal aldimine with PLP via an active site lysine residue, some PLP-dependent enzymes do not have this lysine residue, but instead have a histidine in the active site. In such a case, the histidine cannot form the internal aldimine, and, therefore, the co-factor does not become covalently tethered to the enzyme. GDP-4-keto-6-deoxymannose-3-dehydratase (ColD) is an example of such an enzyme. Human Serine hydroxymethyltransferase 2 regulates one-carbon transfer reactions required for amino acid and nucleotide metabolism, and exists in dimeric and tetrameric forms. The dimeric SHMT2 variant is a potent inhibitor of the BRISC deubiquitylase enzyme complex, which regulates immune-based cell signaling. Recent studies show that SJMT2 tetramerization is induced by PLP. This prevents interaction with the BRISC deubiqutylase complex, potentially linking vitamin B6 levels and metabolism to inflammation.
Another necessary and sufficient condition is that a convex quadrilateral ABCD is tangential if and only if the incircles in the two triangles ABC and ADC are tangent to each other. A characterization regarding the angles formed by diagonal BD and the four sides of a quadrilateral ABCD is due to Iosifescu. He proved in 1954 that a convex quadrilateral has an incircle if and only if
== Example == The decay correct might be used this way: a group of 20 animals is injected with a compound of interest on a Monday at 10:00 a.m. The compound is chemically joined to the isotope copper-64, which has a known half-life of 12.7 hours, or 764 minutes. After one hour, the 5 animals in the "one hour" group are killed, dissected, and organs of interest are placed in sealed containers to await measurement. This is repeated for another 5 animals, at 2 hours, and again at 4 hours. At this point, (say, 4:00 p.m., Monday) all the organs collected so far are measured for radioactivity (a proxy of the distribution of the compound of interest). The next day (Tuesday), the "24 hour" group would be killed and dissected at 10:00 a.m., then measured for radioactivity, (say at 11:00 a.m.). In order to compare ALL the groups together, the data from the "24 hour" must be decay corrected: the radioactivity measured on the second day must be "adjusted" in order to allow a comparison to measurements from an earlier time, but of the same original material. In this case, "time zero" is Monday, 4:00 p.m., when the first three groups (1,2, and 4 hour animals organs) were measured. The "24 hour" group was measured at 11:00 a.m. Tuesday, which is 19 hours after the first groups. Start by calculating the decay constant "K". Substitute 12.7 (hours, the half-life of copper-64) for
Noni tea Oksusu cha, traditional roasted corn tea found in Korea Olive leaf tea Oregano tea Osmanthus tea, dried flowers of the sweet olive tree, are used alone or blended with tea leaves in China. Pandan tea Patchouli tea Pennyroyal leaf, an abortifacient Pine needle tea, or tallstrunt, made from needles of pine trees Qishr, Yemeni drink with coffee husks and ginger Red clover tea Red raspberry leaf Rosa × damascena tea, in the Middle East. Roasted wheat, used in Postum, a coffee substitute Rooibos (red bush), a reddish plant used to make an infusion and grown in South Africa. In the US it is sometimes called red tea. It has many of the antioxidant characteristics of green tea, but because it does not come from tea leaves, it has no caffeine. Rose hip (often blended with hibiscus) Roselle petals (species of hibiscus; known by other names including bissau and dah), consumed in the Sahel and elsewhere Rosemary Sabah snake grass is used as a traditional herbal tea infusion in Southeast Asia. Sagebrush, California sagebrush Sage Sakurayu, Japanese herbal tea made with pickled cherry blossom petals Sassafras roots were steeped to make tea, a practice which was common among Native Americans. They were also used in the flavoring of root beer until being banned by the FDA.
Sources: en.wikipedia.org
President Donald Trump said that Vance, Witkoff, and former senior presidential adviser Jared Kushner are talking to intermediaries in Pakistan on ending the war. He also called the Iran proposal a "significant step" ahead of his Tuesday deadline for Iran to reopen the Strait of Hormuz. Earlier on 7 April, Trump warned that "a whole civilization will die tonight" and will "never be brought back" if Iran does not agree to a deal by midnight (GMT). Later during the day, amidst a two-week ceasefire plan by Pakistan, White House Press Secretary Karoline Leavitt stated that Trump was made aware of the plan. Additionally, it was reported by CBS News that Vance would serve as the US interlocutor in the ceasefire talks. On 8 April, Trump threatened to impose a 50% tariff on any country 'supplying military weapons to Iran.' Also on 8 April, Trump threatened that if no deal is reached by Wednesday when the ceasefire expires, the fighting may resume. On 21 April, Trump said that Iran has violated the ceasefire "numerous times." At an 8 April press conference, Trump said the US will work closely with Iran, talking about the tariff, sanctions and relief. In regard to the Iranian uranium, he stated: "There will be no enrichment of Uranium, and the United States will, working with Iran, dig up and remove all of the deeply buried (B-2 Bombers) Nuclear 'Dust.'" He later added that Lebanon is not included in the ceasefire agreement and that Hezbollah will need to be dealt with: Yeah, they [Lebanon] were not included in the deal . . Because of Hezbollah. They were not included in the deal.
Hemoglobin is the principal determinant of the color of blood (hemochrome). Each molecule has four heme groups, and their interaction with various molecules alters the exact color. Arterial blood and capillary blood are bright red, as oxygen imparts a strong red color to the heme group. Deoxygenated blood is a darker shade of red; this is present in veins, and can be seen during blood donation and when venous blood samples are taken. This is because the spectrum of light absorbed by hemoglobin differs between the oxygenated and deoxygenated states. Blood in carbon monoxide poisoning is bright red, because carbon monoxide causes the formation of carboxyhemoglobin. In cyanide poisoning, the body cannot use oxygen, so the venous blood remains oxygenated, increasing the redness. There are some conditions affecting the heme groups present in hemoglobin that can make the skin appear blue – a symptom called cyanosis. If the heme is oxidized, methemoglobin, which is more brownish and cannot transport oxygen, is formed. In the rare condition sulfhemoglobinemia, arterial hemoglobin is partially oxygenated, and appears dark red with a bluish hue. Veins close to the surface of the skin appear blue for a variety of reasons. However, the factors that contribute to this alteration of color perception are related to the light-scattering properties of the skin and the processing of visual input by the visual cortex, rather than the actual color of the venous blood. Skinks in the genus Prasinohaema have green blood due to a buildup of the waste product biliverdin.
=== Symptoms === Consumption of atractyloside (ATR) in plants will oftentimes also contain carboxyatractyloside (CATR), a highly toxic glycoside. Ingestion of A. gummifera, C. laureola, Xanthium, or their extracts, may result in symptoms of gastrointestinal pain, nausea, diarrhea, and vomiting. Also possible is respiratory depression which may cause hypoxemia, leading to tissue hypoxia, spasms, stiffness, and convulsions. In several cases, these symptoms are followed by coma. Postmortem analysis may indicate hepatocellular damage and renal failure. More recent literature has described sustained application of ATR on skin causing the symptoms described above, including hepatorenal injury.
Sources: en.wikipedia.org
The Australasian Proteomics Society (APS) is a learned society formed in 2004 from the Lorne Proteomics Symposia (LPS) meetings. The APS was expanded to include the Australian Electrophoresis and Proteomics Society (a society formed in 1994 in Sydney, Australia and originally called the Australian Electrophoresis Society, part of the International Council of Electrophoresis Societies). The Lorne Proteomics Symposia meetings can trace their roots to the original Specialist Protein Analysis Workshop (SPAW) founded by Robert L. Moritz and Richard J. Simpson. These meetings began in 1994 as an offshoot of the Lorne Protein Meeting. (established in 1974) to address the needs of protein purification and analysis technologies rapidly under development in the 1980s. The founding president and vice president were Simpson and Moritz. The current president is Stuart Cordwell. In 2004, an Australasia-wide committee was formed to fully disseminate the activities of the APS and provide a regional society to include New Zealand and other interested Asian countries to be a focal hub in the Pacific for the Human Proteome Organization. The aims of the APS are to promote and facilitate proteomics research and related topics. The APS acts a liaison body for communication with state and federal government as well as a central point for the coordination of proteome-related programmes and resources. The APS is a member of the Asia Oceania Human Proteome Organization.
== Technology life cycle == Silica monoliths have only been commercially available since 2001, when Merck began their Chromolith campaign. The Chromolith technology was licensed from Soga and Nakanishi's group at Kyoto University. The new product won the PittCon Editors’ Gold Award for Best New Product, as well as an R&D 100 Award, both in 2001. Individual monolith columns have a life cycle that generally exceeds that of its particulate competitors. When selecting an HPLC column supplier, column lifetime was second only to column-to-column reproducibility in importance to the purchaser. Chromolith columns, for example, have demonstrated reproducibility of 3,300 sample injections and 50,000 column volumes of mobile phase. Also important to the life cycle of the monolith is its increased mechanical robustness; polymeric monoliths are able to withstand pH ranges from 1 to 14, can endure elevated temperatures, and do not need to be handled delicately. “Monoliths are still teenagers,” affirms Frantisec Svec, a leader in the field of novel stationary phases for LC.
Culbertson Jr.; 15,000 people are needed for each shuttle mission; the external tank has a half million gallons of fuel; the shuttle launches on the fourth attempt, two months after the first attempt; at 61,000 ft, it was at 1,700 mph; the rocket boosters were always jettisoned after two minutes and ten seconds; if two engines failed, the shuttle would land at Banjul International Airport in west Africa, if one engine failed, the shuttle would reach orbit; Hubert Brasseux, in charge of the shuttle toilet system - astronauts were strapped down to the toilet, and each had colour-coded individual urinal funnels; the Space Shuttle Orbital Maneuvering System is fired, in preparation for atmospheric entry; reentry occurs on day eleven - the underside reaches 2000C; the orbiter lands at 300 mph.
=== Laboratory preparation === Rarely is there any interest in the synthesis of alkanes, since they are usually commercially available and less valued than virtually any precursor. The best-known method is hydrogenation of alkenes. Many C−X bonds can be converted to C−H bonds using lithium aluminium hydride, Clemmenson reduction, and other specialized routes. Hydrolysis of alkyl Grignard reagents and alkyl organolithium reagents gives alkanes.
Sources: en.wikipedia.org
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.
Synthesis routes, purification steps and the analytical method used all affect the reported figure. A purity number is only comparable when the chromatographic conditions and detection wavelength are stated.
It reports what the supplier measured on a sample, which is useful but not absolute. Independent mass confirmation on the received lot is the more reliable check.
No. TB-500 is a short synthetic peptide matching residues 17 to 23 of thymosin beta-4, while the parent protein contains 43 residues. The fragment lacks the rest of the protein sequence, so the two are related but not identical.